RhumbLine Advisers
LOXO

RhumbLine Advisers’s Loxo Oncology, Inc LOXO Stock Holding History

RhumbLine Advisers’s Portfolio LOXO Stock Details LOXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-37,751
Closed -$5.29M – 2984
2018
Q4 		$5.29M Buy
37,751
+13,524
+56% +$2.05M 0.01% 1075
2018
Q3 		$4.14M Sell
24,227
-1,424
-6% -$239K 0.01% 1230
2018
Q2 		$4.45M Buy
25,651
+4,286
+20% +$644K 0.01% 1180
2018
Q1 		$2.46M Sell
21,365
-708
-3% -$75.3K 0.01% 1487
2017
Q4 		$1.86M Sell
22,073
-3,161
-13% -$264K ﹤0.01% 1664
2017
Q3 		$2.33M Buy
25,234
+2,608
+12% +$203K 0.01% 1519
2017
Q2 		$1.81M Buy
22,626
+5,260
+30% +$291K ﹤0.01% 1636
2017
Q1 		$731K Buy
17,366
+3,118
+22% +$128K ﹤0.01% 2075
2016
Q4 		$458K Buy
14,248
+1,674
+13% +$42.9K ﹤0.01% 2275
2016
Q3 		$329K Buy
12,574
+875
+7% +$22.9K ﹤0.01% 2430
2016
Q2 		$271K Sell
11,699
-958
-8% -$23.9K ﹤0.01% 2586
2016
Q1 		$346K Buy
12,657
+2,185
+21% +$45.7K ﹤0.01% 2453
2015
Q4 		$298K Buy
+10,472
New +$281K ﹤0.01% 2587

Other funds holding LOXO

IUHSA
Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

RhumbLine Advisers's LOXO Position: Q1 2019 in Review

RhumbLine Advisers sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 37,751 shares — an estimated $5.29M sold.

RhumbLine Advisers first reported a position in LOXO in Q4 2015 and held it in 13 quarters. The position peaked at $5.29M in Q4 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

  • RhumbLine Advisers reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
  • RhumbLine Advisers sold 37,751 Loxo Oncology, Inc shares in Q1 2019, an estimated $5.29M.
  • RhumbLine Advisers first reported a position in Loxo Oncology, Inc in Q4 2015 and held it in 13 quarters.
  • RhumbLine Advisers's Loxo Oncology, Inc position peaked at $5.29M in Q4 2018.
  • 1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on RhumbLine Advisers's 13F filing for Q1 2019, filed 1 May 2019.